High IGFBP2 expression correlates with tumor severity in pediatric rhabdomyosarcoma.

[1]  John Condeelis,et al.  The cofilin activity cycle in lamellipodia and invadopodia , 2009, Journal of cellular biochemistry.

[2]  Wei Zhang,et al.  Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas. , 2009, Neuro-oncology.

[3]  G. Fuller,et al.  IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas , 2009, Proceedings of the National Academy of Sciences.

[4]  J. Diehl,et al.  Nuclear cyclin D1: An oncogenic driver in human cancer , 2009, Journal of cellular physiology.

[5]  C. Cordon-Cardo,et al.  Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? , 2009, Cancer letters.

[6]  M. Kearney,et al.  IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis , 2009, Trends in Endocrinology & Metabolism.

[7]  D. Malkin,et al.  Expression of Insulin-Like Growth Factor Pathway Proteins in Rhabdomyosarcoma: IGF-2 Expression is Associated with Translocation-Negative Tumors , 2009, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[8]  R. Sikes,et al.  Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions. , 2009, American journal of translational research.

[9]  S. Leung,et al.  Insulin-Like Growth Factor Binding Protein-2 Is a Novel Therapeutic Target Associated with Breast Cancer , 2008, Clinical Cancer Research.

[10]  Brad T. Sherman,et al.  DAVID gene ID conversion tool , 2008, Bioinformation.

[11]  C. Perks,et al.  IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells , 2007, Oncogene.

[12]  G. Fuller,et al.  Insulin-like growth factor binding protein 2 promotes glioma development and progression , 2007, Proceedings of the National Academy of Sciences.

[13]  S. Nakano,et al.  Silencing of Insulin-like Growth Factor-binding Protein-2 in Human Glioblastoma Cells Reduces Both Invasiveness and Expression of Progression-associated Gene CD24* , 2007, Journal of Biological Chemistry.

[14]  R. Baxter,et al.  Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. , 2007, Endocrinology.

[15]  H. Scher,et al.  Evaluation of Plasma Insulin-like Growth Factor Binding Protein 2 and Her-2 Extracellular Domain as Biomarkers for 17-Allylamino-17-Demethoxygeldanamycin Treatment of Adult Patients with Advanced Solid Tumors , 2007, Clinical Cancer Research.

[16]  S. Horvath,et al.  Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer , 2007, Proceedings of the National Academy of Sciences.

[17]  E. O'regan,et al.  Serum levels of insulin-like growth factors (IGFs) and their binding proteins (IGFBPs), -1, -2, -3, in oral cancer. , 2007, International journal of oral and maxillofacial surgery.

[18]  G. Lanfranchi,et al.  Defining the gene expression signature of rhabdomyosarcoma by meta-analysis , 2006, BMC Genomics.

[19]  G. Prendergast,et al.  Cyclin D1 Functions in Cell Migration , 2006, Cell cycle.

[20]  A. Hoeflich,et al.  IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T. , 2006, Journal of molecular endocrinology.

[21]  T. Triche,et al.  Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. , 2006, Cancer research.

[22]  Cesare Furlanello,et al.  Gene expression profiling identifies potential relevant genes in alveolar rhabdomyosarcoma pathogenesis and discriminates PAX3‐FKHR positive and negative tumors , 2006, International journal of cancer.

[23]  G. Fuller,et al.  An Interaction between Insulin-like Growth Factor-binding Protein 2 (IGFBP2) and Integrin α5 Is Essential for IGFBP2-induced Cell Mobility* , 2006, Journal of Biological Chemistry.

[24]  David M. Thomas,et al.  Gene expression profiling of sarcomas. , 2006, Pathology.

[25]  A. Hoeflich,et al.  Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. , 2005, Endocrinology.

[26]  M. Capecchi,et al.  New genetic tactics to model alveolar rhabdomyosarcoma in the mouse. , 2005, Cancer research.

[27]  C. Tacchetti,et al.  The ocular albinism type 1 (OA1) protein and the evidence for an intracellular signal transduction system involved in melanosome biogenesis. , 2005, Pigment cell research.

[28]  W. Blum,et al.  Insulin-like growth factor binding protein-2 at diagnosis of childhood acute lymphoblastic leukemia and the prediction of relapse risk. , 2005, The Journal of clinical endocrinology and metabolism.

[29]  I. Shmulevich,et al.  Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion , 2005, Molecular Cancer.

[30]  Michael A. Gonzalez,et al.  Cell‐cycle‐dependent regulation of DNA replication and its relevance to cancer pathology , 2005, The Journal of pathology.

[31]  M. Elmlinger,et al.  Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. , 2004, Journal of molecular endocrinology.

[32]  Susan L. Forsburg,et al.  Eukaryotic MCM Proteins: Beyond Replication Initiation , 2004, Microbiology and Molecular Biology Reviews.

[33]  Joseph J. Pereira,et al.  Bimolecular Interaction of Insulin-Like Growth Factor (IGF) Binding Protein-2 with αvβ3 Negatively Modulates IGF-I-Mediated Migration and Tumor Growth 1 , 2004, Cancer Research.

[34]  G. Fuller,et al.  IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. Fuller,et al.  Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. , 2003, Cancer research.

[36]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[37]  R. Baxter,et al.  Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.

[38]  M. Bittner,et al.  Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. , 2002, The American journal of pathology.

[39]  P. Sorensen,et al.  PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  M. Kattan,et al.  Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[42]  K. Pritchard-Jones,et al.  PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma. , 2001, The American journal of pathology.

[43]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[44]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  W. Yung,et al.  Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. , 1999, Cancer research.

[46]  J. Kok,et al.  N-Ras induces alterations in Golgi complex architecture and in constitutive protein transport. , 1999, Journal of cell science.

[47]  L. Helman,et al.  Rhabdomyosarcoma: an overview. , 1999, The oncologist.

[48]  D. Trono,et al.  A Third-Generation Lentivirus Vector with a Conditional Packaging System , 1998, Journal of Virology.

[49]  T. Pozzan,et al.  The Golgi apparatus is an inositol 1,4,5‐trisphosphate‐sensitive Ca2+ store, with functional properties distinct from those of the endoplasmic reticulum , 1998, The EMBO journal.

[50]  F. Barr.  Molecular Genetics and Pathogenesis of Rhabdomyosarcoma , 1997, Journal of pediatric hematology/oncology.

[51]  Robert Presley,et al.  Evolutionary biology: Pelvic problems for mammals , 1997, Nature.

[52]  Jennifer Lippincott-Schwartz,et al.  ER-to-Golgi transport visualized in living cells , 1997, Nature.

[53]  Y. Misumi,et al.  Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. , 1986, The Journal of biological chemistry.

[54]  Chun Deng,et al.  Relationship between Matrix Metalloproteinase 2 and Lung Cancer Progression , 2012, Molecular Diagnosis & Therapy.

[55]  P. Pinton,et al.  Biosensors for the detection of calcium and pH. , 2007, Methods in cell biology.

[56]  W. Liang,et al.  9) TM4 Microarray Software Suite , 2006 .

[57]  W. Liang,et al.  TM4 microarray software suite. , 2006, Methods in enzymology.

[58]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[59]  W. Denzo,et al.  ER-to-Golgi transport visualized in living cells , 1997 .

[60]  E. Kuismanen,et al.  Low temperature-induced transport blocks as tools to manipulate membrane traffic. , 1989, Methods in cell biology.

[61]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .